Autophagy Inhibition in Pancreatic Adenocarcinoma

Brian A. Boone, Herbert J. Zeh, Nathan Bahary

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Although some progress has been made in recent years with the development of more effective chemotherapy regimens, new treatment approaches are needed to improve outcomes for patients with pancreatic adenocarcinoma. The cellular process of autophagy, a cell survival mechanism that allows cancer cells to survive the hazardous conditions of the tumor microenvironment and treatment, has emerged as a viable target in pancreatic cancer. We review the mechanism of autophagy, its role in pancreatic carcinogenesis, the preclinical and clinical evidence supporting targeting autophagy in patients with pancreatic adenocarcinoma, and areas of future investigation that hold promise for improving this treatment approach.

Original languageEnglish (US)
Pages (from-to)25-31
Number of pages7
JournalClinical Colorectal Cancer
Volume17
Issue number1
DOIs
StatePublished - Mar 2018
Externally publishedYes

Fingerprint

Autophagy
Adenocarcinoma
Tumor Microenvironment
Pancreatic Neoplasms
Cell Survival
Carcinogenesis
Therapeutics
Drug Therapy
Neoplasms

Keywords

  • Apoptosis
  • Chloroquine
  • Damage-associated molecular pattern molecule (DAMP)
  • High-mobility group box 1 (HMGB1)
  • Hydroxychloroquine

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Autophagy Inhibition in Pancreatic Adenocarcinoma. / Boone, Brian A.; Zeh, Herbert J.; Bahary, Nathan.

In: Clinical Colorectal Cancer, Vol. 17, No. 1, 03.2018, p. 25-31.

Research output: Contribution to journalReview article

Boone, Brian A. ; Zeh, Herbert J. ; Bahary, Nathan. / Autophagy Inhibition in Pancreatic Adenocarcinoma. In: Clinical Colorectal Cancer. 2018 ; Vol. 17, No. 1. pp. 25-31.
@article{f390de6b13594860a100b49f4d6bf01e,
title = "Autophagy Inhibition in Pancreatic Adenocarcinoma",
abstract = "Although some progress has been made in recent years with the development of more effective chemotherapy regimens, new treatment approaches are needed to improve outcomes for patients with pancreatic adenocarcinoma. The cellular process of autophagy, a cell survival mechanism that allows cancer cells to survive the hazardous conditions of the tumor microenvironment and treatment, has emerged as a viable target in pancreatic cancer. We review the mechanism of autophagy, its role in pancreatic carcinogenesis, the preclinical and clinical evidence supporting targeting autophagy in patients with pancreatic adenocarcinoma, and areas of future investigation that hold promise for improving this treatment approach.",
keywords = "Apoptosis, Chloroquine, Damage-associated molecular pattern molecule (DAMP), High-mobility group box 1 (HMGB1), Hydroxychloroquine",
author = "Boone, {Brian A.} and Zeh, {Herbert J.} and Nathan Bahary",
year = "2018",
month = "3",
doi = "10.1016/j.clcc.2017.10.013",
language = "English (US)",
volume = "17",
pages = "25--31",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Autophagy Inhibition in Pancreatic Adenocarcinoma

AU - Boone, Brian A.

AU - Zeh, Herbert J.

AU - Bahary, Nathan

PY - 2018/3

Y1 - 2018/3

N2 - Although some progress has been made in recent years with the development of more effective chemotherapy regimens, new treatment approaches are needed to improve outcomes for patients with pancreatic adenocarcinoma. The cellular process of autophagy, a cell survival mechanism that allows cancer cells to survive the hazardous conditions of the tumor microenvironment and treatment, has emerged as a viable target in pancreatic cancer. We review the mechanism of autophagy, its role in pancreatic carcinogenesis, the preclinical and clinical evidence supporting targeting autophagy in patients with pancreatic adenocarcinoma, and areas of future investigation that hold promise for improving this treatment approach.

AB - Although some progress has been made in recent years with the development of more effective chemotherapy regimens, new treatment approaches are needed to improve outcomes for patients with pancreatic adenocarcinoma. The cellular process of autophagy, a cell survival mechanism that allows cancer cells to survive the hazardous conditions of the tumor microenvironment and treatment, has emerged as a viable target in pancreatic cancer. We review the mechanism of autophagy, its role in pancreatic carcinogenesis, the preclinical and clinical evidence supporting targeting autophagy in patients with pancreatic adenocarcinoma, and areas of future investigation that hold promise for improving this treatment approach.

KW - Apoptosis

KW - Chloroquine

KW - Damage-associated molecular pattern molecule (DAMP)

KW - High-mobility group box 1 (HMGB1)

KW - Hydroxychloroquine

UR - http://www.scopus.com/inward/record.url?scp=85042442074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042442074&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2017.10.013

DO - 10.1016/j.clcc.2017.10.013

M3 - Review article

C2 - 29223362

AN - SCOPUS:85042442074

VL - 17

SP - 25

EP - 31

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 1

ER -